Do microplastics in tumors make cancer immunotherapy work worse?
Yes. Research shows that microplastics found inside tumors can cause immunotherapy to fail by disrupting how the body fights cancer cells.
What's actually in it
Microplastics are tiny pieces of plastic that have been found everywhere, including inside human tumors. These particles are not inert. They interact with your body at a biological level. According to a 2026 study in J Hazard Mater, these plastics represent a hidden threat to cancer biology.
When these particles enter a tumor, they don't just sit there. They actively interfere with the signals your body uses to identify and destroy cancer cells. This creates a physical and chemical environment that makes it much harder for medical treatments to do their job.
What the research says
Peer-reviewed research has confirmed that the presence of these plastics directly impacts the success of cancer treatment. A 2026 study in Mol Cancer found that microplastics that get into tumors disrupt the JAK-STAT-microbiota axis. This is a critical pathway your immune system uses to fight disease.
By breaking this pathway, the microplastics promote resistance to immunotherapy. This means the medicine you are given to help your body fight the cancer becomes less effective. The science is clear: these foreign plastic particles change how your body responds to life-saving treatment.
The research at a glance
| Study | Journal | Year |
|---|---|---|
| Tumour-infiltrating microplastics disrupt the JAK-STAT-microbiota axis to promote immunotherapy resistance in colorectal cancer. | Mol Cancer | 2026 |
| The hidden threat: Microplastics and cancer biology. | J Hazard Mater | 2026 |
What to use instead
Browse our vetted, non-toxic alternatives. Every product is third-party certified.
Shop Non-Toxic Home